Valuation Fennec Pharmaceuticals Inc. Toronto S.E.

Stocks

Market Closed - Toronto S.E. 10:25:44 2026-09-21 EDT			5-day change	1st Jan Change
15.00 ^CAD	0.00%		+3.23%	+41.51%

09-17	Fennec Pharmaceuticals Announces Oral Presentation Of Detailed Results From Investigator-Initiated Phase 2 STS-J01 Clinical Study Of Pedmark In Japan At SIOP 2026	CI
08-12	B. Riley Adjusts Fennec Pharmaceuticals Price Target to $18 From $16, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	114.4	252.1	302.9	173.6	263	386.1	-	-
Change	-	120.31%	20.14%	-42.68%	51.48%	46.81%	-	-
Enterprise Value (EV)	114.4	252.1	302.9	173.6	263	386.1	386.1	386.1
Change	-	120.31%	20.14%	-42.68%	51.48%	46.81%	0%	0%
P/E	-6.57x	-10.7x	-18.7x	-	-22x	36.7x	11.1x	6.15x
PBR	-	-	-	-	-	-	-	-
PEG	-	-0.3x	0.6x	-	-	-0x	0x	0.1x
Capitalization / Revenue	-	164x	14.3x	3.65x	5.89x	5.32x	3.74x	2.78x
EV / Revenue	-	0x	0x	0x	0x	5.32x	3.74x	2.78x
EV / EBITDA	-	-	-	-	0x	22.1x	11.7x	7.86x
EV / EBIT	-0x	-0x	-0x	0x	-0x	39.6x	11x	5.88x
EV / FCF	-	-	-0x	0x	-0x	33.9x	12.6x	7x
FCF Yield	-	-	-5.66%	15.5%	-4.74%	2.95%	7.96%	14.3%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.67	-0.9	-0.6	-	-0.35	0.3	0.988	1.79
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	-	1.535	21.25	47.54	44.64	72.56	103.1	138.9
EBITDA ¹	-	-	-	-	0.392	17.5	33.1	49.1
EBIT ¹	-17.22	-22.59	-12.77	2.568	-6.744	9.738	35.04	65.68
Net income ¹	-17.35	-23.71	-16.04	-0.07	-10.1	10.48	35.13	64.6
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	4.40	9.60	11.22	6.32	7.70	11.01	11.01	11.01
Nbr of stocks (in thousands)	26,007	26,261	26,994	27,470	34,153	35,067	-	-
Announcement Date	2/28/22	3/29/23	3/21/24	3/10/25	3/24/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	33.27x	12.06x	24.51x	0.59%	1,043B
JOHNSON & JOHNSON	29.94x	6.66x	18.64x	2%	649B
ABBVIE INC.	33.54x	7.85x	16.21x	2.59%	469B
ROCHE HOLDING AG	19.72x	4.82x	11.95x	2.75%	355B
NOVARTIS AG	20.01x	5.21x	12.94x	3.07%	270B
ASTRAZENECA PLC	21.55x	4.46x	12.7x	1.98%	262B
AMGEN INC.	26.04x	6.76x	12.04x	2.46%	222B
GILEAD SCIENCES, INC.	-46.18x	6.71x	26.22x	2.16%	189B
NOVO NORDISK A/S	11.59x	4.21x	8.76x	4.34%	175B
Average	16.61x	6.53x	16.00x	2.44%	403.67B
Weighted average by Cap.	23.93x	7.81x	18.02x	1.97%